Published in Virus Res on July 01, 1993
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol (1994) 1.70
Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol (2010) 0.87
The microbiology of human hygiene and its impact on type 1 diabetes. Islets (2012) 0.81
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell (1991) 13.69
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature (2000) 9.80
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (1992) 9.30
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science (2001) 8.93
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med (1995) 8.15
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science (1985) 6.02
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses (1990) 5.79
A role for carbohydrates in immune evasion in AIDS. Nat Med (1998) 5.06
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89
Four novel U RNAs are encoded by a herpesvirus. Cell (1988) 3.86
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol (1996) 3.84
Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science (1985) 3.74
Significance of premature stop codons in env of simian immunodeficiency virus. J Virol (1989) 3.60
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol (1991) 3.46
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci U S A (1979) 3.24
Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol (1987) 3.18
Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology (1994) 3.16
Statistical models for prevalent cohort data. Biometrics (1993) 3.16
Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol (1992) 3.16
Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat Med (1997) 3.11
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell (1995) 3.03
Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS (1987) 3.01
Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A (1992) 2.94
Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol (1997) 2.90
Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses (1994) 2.72
Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol (1993) 2.70
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol (1999) 2.69
Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol (1993) 2.65
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65
Titration and characterization of two rhesus-derived SIVmac challenge stocks. AIDS Res Hum Retroviruses (1994) 2.63
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol (1996) 2.61
Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J (1986) 2.60
Comparison of simian immunodeficiency virus isolates. Nature (1988) 2.55
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J Virol (1986) 2.52
The construction and analysis of epidemic trees with reference to the 2001 UK foot-and-mouth outbreak. Proc Biol Sci (2003) 2.49
A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol (1997) 2.41
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.36
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol (1989) 2.33
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol (1989) 2.29
Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol (1987) 2.29
The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology (1990) 2.28
Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28
Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol (1997) 2.27
Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol (1984) 2.25
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science (1984) 2.22
Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses (1994) 2.18
Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci U S A (1991) 2.18
The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol (2000) 2.15
Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri. J Virol (1984) 2.14
Effects of mid-point imputation on the analysis of doubly censored data. Stat Med (1992) 2.09
Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation. J Virol (1984) 2.09
Virus-encoded cyclin. Mol Cell Biol (1994) 2.06
Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology (2003) 2.06
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Origins of the CSF outbreak. Vet Rec (2000) 2.00
Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus. Biochemistry (1975) 1.96
Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol (1998) 1.90
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Prevalence of dementia after age 90: results from the 90+ study. Neurology (2008) 1.88
Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J Virol (1991) 1.84
Herpesvirus saimiri strain variability. J Virol (1982) 1.80
Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol (1993) 1.77
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol (1994) 1.77
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol (1995) 1.72
Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol (1997) 1.71
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol (1994) 1.70
A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res Hum Retroviruses (1992) 1.70
Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med (1999) 1.69
Association of the viral oncoprotein STP-C488 with cellular ras. Mol Cell Biol (1995) 1.66
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
Sexual transmission of SIVagm in wild grivet monkeys. J Med Primatol (1994) 1.63
Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann Neurol (1988) 1.63
Modelling paired survival data with covariates. Biometrics (1989) 1.59
Epidemiology. Foot-and-mouth disease under control in the UK. Nature (2001) 1.57
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J Virol (2000) 1.57
Herpesvirus saimiri DNA in tumor cells--deleted sequences and sequence rearrangements. J Virol (1981) 1.55
Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54
Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol (1987) 1.54